Ved langvarig behandling på mere end 2 år tilrådes regelmæssig revurdering for at bekræfte, at det fortsat er hensigtsmæssigt for patienten at fortsætte den valgte behandling.
With prolonged treatment for more than 2 years, regular reassessment is recommended to confirm that continuing the selected therapy remains appropriate for the patient.